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ABSTRACT 
 
Staphylococcus aureus bacterial infection is a serious problem in medicine.  The initial 
and necessary step in virtually all S. aureus infections is binding of a bacterium to surfaces 
within a host (e.g., tissue or indwelling device).  One of the most important binding reactions is 
between human fibronectin (e.g., presented on endothelial cells or coatings on prosthetic heart 
values) and fibronectin-binding proteins produced on the surface of S. aureus. I propose that S. 
aureus isolates that exhibit a clinically complicated progression of infection will show stronger 
and more frequent binding to fibronectin-coated surfaces in vitro.  This study used methicillin-
resistant S. aureus (MRSA) isolates from two distinct clinical populations: patients whose 
bacterial infection resolved within 4 days of antibiotic treatment (n = 7; resolving bacteremia; 
RB), and patients who still had positive MRSA blood cultures after ≥7 days of receiving 
antibiotics (n = 7; persistent bacteremia; PB).  Fibronectin binding was experimentally measured 
by using atomic force microscopy (AFM) to probe attractive forces between a fibronectin-coated 
AFM tip and putative fibronectin-binding receptors on S. aureus cells from each of the 14 
isolates.  The bacterial isolates that originated from patients that had PB showed statistically 
higher binding frequency (p = 0.0218), force of binding (p <0.0001), and energy of binding (p 
<0.0001) relative to RB isolates.  These measurements suggest that binding to fibronectin is 
associated with increased risk of serious infection by S. aureus.  
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Tables and Figures 
 
Table 1.  List of S. aureus isolates analyzed by AFM. 
 
 
Table  2.  List of the binding frequency, maximum binding force (nanoNewton; 10-9 N), and  
 
work of adhesion (attoJoules; 10-18 J) for each of the 14 isolates. 
 
 
Table 3.  P values for analysis of force curve data.   
 
 
Figure 1.  Binary fission pair of S. aureus cells about to be probed by a fibronectin-coated tip.  
 
 
Figure 2.  Retraction force profiles. 
 
 
Figure 3.  Box plots showing the frequency of binding of S. aureus to a fibronectin-coated  
 
surface. 
 
 
Figure 4.  Box plots showing the maximum binding force for S. aureus to a fibronectin-coated  
 
surface.  
 
 
Figure 5.  Box plots showing the binding energy (attoJoules; 10-18 J) for S. aureus to a  
 
fibronectin-coated surface.
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INTRODUCTION 
 
Staphylococcus aureus is a Gram-positive inhabitant of the nasal passages and skin of 
humans, and can cause mild to severe infection if it enters the bloodstream (28). S. aureus is now 
recognized as the leading cause of bacteremia and infective endocarditis in the industrialized 
world (4).  A significant number of bloodstream infections are due to methicillin-resistant S. 
aureus (MRSA), which tend to be associated with inferior clinical outcome and longer 
hospitalization than methicillin-susceptible S. aureus (23).  Persistent bacteremia (PB) outcomes 
comprise 20-30% of all episodes of MRSA bacteremia (25).  Why some MRSA bacteremia 
strains persist while others resolve (resolving bacteremia, RB) despite similar clinical and 
microbiologic characteristics, as well as similar surgical and therapeutic strategies is poorly 
understood.  
One possible explanation is that organisms associated with persistent infections have a 
greater ability to endure, invade and proliferate at initial infection sites associated with 
endocarditis (25).  Upon entering the bloodstream, S. aureus must avoid being cleared by host 
defense mechanisms.  In addition to persisting in the bloodstream, the organism must adhere to 
damaged cardiac valve endothelium to initiate infective endocarditis.  In order to persistently 
infect such sites, S. aureus must subsequently invade the cardiac endothelial cells (i.e., 
endocardium).   
Here, I investigate the initial step in infective endocarditis, that is, adherence of S. aureus 
to a surface.  Endothelial and endocardium cells present a number of ligand molecules to which 
S. aureus can bind.  Fibronectin (Fn) is one of the most important host ligands as S. aureus 
express two important Fn-binding proteins (FnBPA and FnBPB) that help this organism adhere 
to surfaces (22).  Animal studies have demonstrated that native valve endocarditis is associated 
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with secretion of fibronectin at the point of injury of endothelium in aortic valves (5).  Similarly, 
in vivo studies of humans demonstrate that foreign materials (e.g., intravenous catheter, central 
venous catheter, ventricular assist device) become coated with plasma proteins like fibronectin, 
and S. aureus use primarily FnBPs for attachment and initial colonization of an implanted 
devices (1, 10, 26, 27).  Other studies show that S. aureus use FnBP to bind to other host 
molecules such as human heat shock protein 60 as well as β1 integrins through a fibronectin 
bridge (6).   
In this study, atomic force microscopy (AFM) is used to directly probe the binding 
mechanism between a fibronectin-coated substrate and putative FnBPs expressed on the outer 
surface of individual S. aureus cells immersed in buffer solution.  These experiments were 
conducted with 14 different isolates of S. aureus obtained from patients with persistent (n = 7) or 
resolving bacteremia (n = 7).  I determined the activity or frequency of binding, the maximum 
binding force (measured in nanoNewtons), and the work or energy of binding (measured in 
attoJoules) for each of the 14 isolates.  These data were analyzed to determine whether there 
were differences in fibronectin binding between the PB and RB groups.  I also compared the 
AFM data by grouping the 14 isolates into their respective clonal complexes, as determined by 
multi-locus sequence typing (7).   
By determining how known invasive and non-invasive isolates of S. aureus (i.e. PB vs. 
RB) bind to fibronectin-coated surfaces, a method may be developed to identify isolates that are 
likely to be pathogenic.  Patients who naturally harbor such “invasive” isolates may be 
forewarned of the risks associated with certain future surgical procedures (e.g. heart valve 
replacement) and receive prophylactic antibiotic treatment before surgery.   
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MATERIALS AND METHODS 
Bacteria specimens and growth conditions. 
Methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 14) were kindly 
provided by Dr. Arnold Bayer from the University of California at Los Angeles Medical Center.  
All MRSA isolates used in this study, originated from a multinational S. aureus bacteremia 
clinical trial collection conducted between 2002 and 2005 (8).  MRSA isolates came from 
patients who were well matched for epidemiologic, demographic, and clinical features and were 
grouped into persistent bacteremia (PB) and resolving bacteremia (RB) cohorts based on clinical 
blood culture data, as described below (25).  All 14 patients (where MRSA isolates were 
obtained from) used in the present study had complicated MRSA bacteremia and/or infective 
endocarditis, and all received either daptomycin mono- therapy or dual-drug standard therapy 
consisting of vancomycin plus low-dose, short-course aminoglycosides (25). 
Study isolates were grouped according to clinical blood culture data: PB (n = 7) was 
defined as ≥7 days of positive MRSA blood culture despite receiving antibiotics to which the 
isolate was susceptible; RB (n = 7) was defined as an initial positive MRSA blood culture with 
subsequent negative blood cultures 2 to 4 days after initiation of antibiotic therapy.  
Genetic profiling using PCR was used to assign isolates to multilocus sequence typing 
(MLST)-defined clonal complexes (CCs).  MLST has been used as a definite method for 
assigning MRSA and MSSA isolates to known clonal complex groups or to assign them as novel 
groups (7).  This method of grouping S. aureus has been validated by showing that pairs of 
isolates with identical allelic profiles produced similar SmaI restriction fragment patterns by 
pulsed-field gel electrophoresis (7). CC5 (n = 5) and CC45 (n = 5) are represented among 10 of 
the MRSA isolates, where the other 4 isolates are either CC1 or CC8.  
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The S. aureus isolates used in atomic force microscopy (AFM) experiments were grown 
from cryogenically preserved samples.  The S. aureus isolates were incubated at 37 °C in tryptic 
soy broth supplemented with 0.25% dextrose.  S. aureus has shown expression of microbial 
surface components (such as FnBPA and FnBPB) recognizing adhesive matrix molecules when 
cultured under these conditions (16, 29).  
Fibronectin binding as determined by atomic force microscopy (AFM)  
 Each isolate was harvested at mid-exponential phase (OD600 = 0.51 ± 0.02).  One mL of 
cell suspension was centrifuged at 5000 xg for 3 min.  The resulting pellet of cells was washed 
and resuspended in saline buffer three times.  After washing, the cells were suspended in 
phosphate-buffered saline (PBS).  One-hundred µL of the washed cell suspension was 
transferred onto fibronectin-coated slides (BD Biosciences) and allowed to adhere for 5 min. 
Unbound cells then were washed off by a gently flowing solution of ~10 mL of PBS solution.  
Force measurements of S. aureus were collected using silicon nitride AFM cantilevers 
(nominal radius 20 nm, measured spring constant 0.1 ± 0.06 nN nm−1).  The cantilevers were 
cleaned by sequential washing with approximately 10 mL acetone, 10 mL 70% ethanol, and 10 
mL distilled water.  The cantilevers were coated with fibronectin by immersing in a 100 µg/mL 
fibronectin (Sigma-Aldrich) PBS solution for 45 min and rinsed with PBS solution (2).   
Force measurements were performed in a PBS solution using an atomic force microscope 
(Veeco/Digital Instruments Bioscope AFM and NanoSCOPE IV controller) as previously 
described (29).  Briefly, an inverted optical microscope (Axiovert 200M; Zeiss) was used to 
position a fibronectin-coated cantilever tip over an individual S. aureus cell or binary fission pair 
within the AFM (Figure 1).  Forces were measured on cells immersed in PBS solution (pH 7.4) 
as previously described (20, 21).  The tip was pressed against a cell until the cantilever was 
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flexed 100 nm.  A single approach–retraction cycle took 1–2 s.  The vertical travel of the z-
piezoelectric scanner was 2.7 µm.  Data acquisition was confined to a narrow window after 
harvesting (<30 min) to minimize data collection on quiescent bacteria. 
 
Figure 1.  Binary fission pair of S. aureus cells (red arrow) about to be probed by a fibronectin-coated tip 
(blue arrow).  The black arrow indicates the cantilever.  The cells are supported on a fibronectin-coated 
glass slide. Image collected at 100X using a Zeiss confocal microscope. 
 
 
RESULTS 
Collection of data 
AFM was performed with fibronectin coated AFM tips on S. aureus cells. Tips were 
positioned over individual cells or binary cell pairs (see Fig. 1).  Fn-coated tips were pushed 
against and retracted from individual cells at a rate of 0.996 Hz, that is, approximately one 
approach-retraction cycle per second. This method allows one to directly measure the force of 
interaction between Fn on the AFM tip (i.e., proxy for a host cell displaying Fn or Fn-coated 
indwelling device) and Fn-binding proteins on S. aureus.   
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Figure 2 presents typical force retraction curves.  The red-colored curve in Figure 2 
shows the interaction when the fibronectin-coated tip was pulled from contact with one of the PB 
S. aureus cells.  As the tip was retracted to ~500 nm there was one unbinding event followed by 
a second event at a separation of approximately 1000 nm.  Both binding events exhibit a non-
linear, force-distance response.  These types of binding (or unbinding) events were observed for 
all 14 of the isolates used in this study.  An average of 16.5 different cells were analyzed for each 
of the 14 isolates (range of 7 to 28 cells per isolate) (Table 1).  
 
____________________________________________________________________________________ 
▲ indicates for maximum force of adhesion 
/// shading indicates the area above the curve (energy) 
 
Figure 2.  Retraction force profiles collected for a fibronectin-coated tip on a glass substrate (blue) or S. 
aureus cells classified as persistent (PB; gold) or resolving (RB; red) bacteremia.  The approach curves 
are not shown in this figure for clarity.  Attractive forces (nanoNewtons; 10-9 N) are given a negative sign 
by convention.  Triangles highlight force values used in data analysis.  The red-colored region represents 
the energy (in attoJoules) of interaction. 
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Table 1.  List of S. aureus isolates analyzed by AFM.  PB isolates are represented in bold text, RB 
isolates are denoted with normal font.  The clonal complex (CC) of each isolate is shown in parentheses.  
Shown is the total number of different cells analyzed for each isolate with AFM, the total number of 
binding curves collected for each isolate, and the number of force curves that exhibited an attractive 
interaction (including both non-specific and specific interactions). 
 
isolate # of cells analyzed 
total # of 
force 
curves  
# with 
attractive 
interaction 
300-169 (45) 10 614 310 
324-136 (45) 25 1510 1091 
301-188 (45) 18 1002 428 
300-087 (45) 9 891 33 
300-103 (45) 7 497 52 
300-246 (5) 8 549 521 
088-180 (5) 9 694 55 
077-107 (5) 24 1134 789 
088-237 (5) 19 1119 853 
010-016 (5) 8 598 162 
031-038 (8) 24 1196 1040 
300-111 (8) 22 1246 1046 
027-017 (8) 24 1010 598 
067-227 (1) 28 1691 541 
    
 
Control experiments were performed to ensure that the unbinding events, mentioned 
above, were due to interactions that formed between fibronectin on the tip and fibronectin-
binding molecules on S. aureus.  The blue-colored curve in Figure 2 shows the interaction 
between a fibronectin-coated tip and the fibronectin-slides, which were used to support the S. 
aureus cells.  As is clearly illustrated, there was a distinct difference in the force spectra for the 
Fn-Fn control vs. the fibronectin-cell experiments.  This difference suggests that binding events 
observed on S. aureus (e.g., red and gold curves in Fig. 2) are due to fibronectin binding to Fn-
binding receptors, FnBPA and/or FnBPB, on S. aureus.  The control experiment (i.e., probing the 
Fn-tip against the Fn-coated slide) was also performed between analyses of different samples to 
ensure that the tip was free of contamination (e.g., ensure that cells were not sticking to the AFM 
tip).    
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Because I was interested in identifying binding events associated with FnBPs on S. 
aureus, I attempted to identify a binding-signature specific to protein interactions.  Force profiles 
on S. aureus resulted in both linear and non-linear force-distance responses (see Fig. 2).  By 
working with strains of Lactococcus lactis that produce only FnBP on their outer surface, others 
have demonstrated that non-linear force profiles indicate specific interactions involving 
fibronectin and/or FnBP (2).  For the force curve analyses, I focused only on those nonlinear 
unbinding events that had a force greater than 0.5 nanoNewtons and a separation greater than 
200 nm.   
Frequency of binding to fibronectin 
A protein-mediated binding event was defined as a retraction curve that exhibited a non-
linear, sawtooth force-distance profile (Figure 2).  Some binding profiles displayed more than 
one sawtooth waveform (two sawteeth in a single force-distance profile) but were counted as a 
single binding event as previously described (2).  Binding frequencies were calculated by 
dividing all the non-linear interactions by the total number of curves collected on cells for the 
isolate being analyzed (Table 1 and 2).  Figure 3 represents binding frequencies for all isolates 
when comparing CC45 (n = 5) to CC5 (n = 5) and PB (n = 7) to RB (n = 7).   
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Table  2.  List of the binding frequency, maximum binding force (nanoNewton; 10-9 N), and work of 
adhesion (attoJoules; 10-18 J) for each of the 14 isolates. PB isolates are represented in bold text, RB 
isolates are denoted with normal font.  The clonal complex (CC) of each isolate is shown in parentheses.  
The standard deviations for maximum force values and energy values are indicated after the value. 
       
Isolatea  
binding 
freq.b  
max. force 
(nN)  
energy 
(aJ) 
300-169 (45)  50.5  2.69 ± 1.43  46.4 ± 31.9 
324-136 (45)  72.3  2.69 ± 1.42  80.9 ± 40.6 
301-188 (45)  42.7  5.95 ± 3.92  337 ± 341 
300-087 (45)  3.7  1.01 ± 0.723  11.8 ± 10.2 
300-103 (45)  10.5  0.978 ± 0.883  14.0 ± 20.3 
300-246 (5)  94.9  4.69 ± 2.98  472 ± 248 
088-180 (5)  7.9  3.73 ± 2.83  147 ± 140 
077-107 (5)  69.6  14.1 ± 8.93  1037 ± 997 
088-237 (5)  76.2  7.59 ± 4.33  516 ± 408 
010-016 (5)  27.1  0.981 ± 0.434  15.9 ± 10.3 
031-038 (8)  87.0  13.6 ± 6.00  976 ± 568 
300-111 (8)  83.9  13.5 ± 9.06  666 ± 511 
027-017 (8)  59.2  3.32 ± 1.74  120 ± 85.4 
067-227 (1)  32.0  4.99 ± 2.63  244 ± 222 
 
 
a Clonal complex follows isolate number in parentheses 
b Binding frequency is given as % 
 
 
Comparison of PB and RB groups using Student’s t-test shows statistically significant 
differences between the PB and RB isolate groups (p < 0.05; Table 3).  In addition, CC45 
isolates have a median binding frequency of 0.40 whereas isolates described by CC5 have a 
median binding frequency of 0.67.  CC45 and CC5 were not quite significantly different (p = 
0.0682) upon comparison of their binding frequencies.  However, all five CC45 isolates were 
shown to be statistically significantly different from CC8/1 (p = 0.0124).  
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Figure 3.  Box plots showing the frequency of binding of S. aureus to a fibronectin-coated surface.  The 
upper portion each box represent the 75th percentile and the lower portion represent the 25th percentile.  
The upper part of each line represents the 91st percentile and the lower portion represents the 9th 
percentile.  The median is represented by a horizontal line and numerically below the line.  P-values 
represented the comparison of the (i) PB vs. RB and (ii) CC45 vs. CC5 groupings.  
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Table 3.  P values for analysis of force curve data.  The p values were calculated using an unpaired 
Students t-test.  Each comparison is between entire groups of clinical isolates (i.e. PB vs. RB). 
 
groups compared binding freq max. force energy 
	   	   	   	  
CC5 vs. CC45 p = 0.0682 p = 0.0001*** p = 0.0001*** 
CC45 vs. CC8/1 p = 0.0124* p = 0.0001*** p = 0.0001*** 
CC 5 vs. CC8/1 p = 0.6714 p = 0.0007*** p = 0.1016 
PB vs. RB p = 0.0218* p = 0.0001*** p = 0.0001*** 
__________________________________________________________________________ 
*P <0.05 and ***P <0.001 
 
Maximum binding force toward fibronectin 
Only force-distance profiles that exhibited a sawtooth curve (without other non-specific 
interactions) were analyzed for maximal force and energy values using SPIP™ software.  These 
types of profiles were detected in 9% of the collected curves. Multiple force maximums were 
assigned to profiles that had more than one sawtooth (Fig. 2).  Figure 4 are box-and-whisker 
plots of the force maximal values for CC45, CC5, PB, and RB groupings of isolates.  Using 
Student’s t-test, the PB group was shown to be statistically different from the RB group (p < 
0.0001).  In addition, the CC45 group was shown to be statistically different the CC5 group (p < 
0.0001). Comparison of other CC groups is described in Table 3. 
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Figure 4.  Box plots showing the maximum binding force for S. aureus to a fibronectin-coated surface. 
The upper portion each box represent the 75th percentile and the lower portion represent the 25th 
percentile.  The upper part of each line represents the 91st percentile and the lower portion represents the 
9th percentile.  The median is represented by a horizontal line and numerically below the line. P-values 
represented the comparison of the (i) PB vs. RB and (ii) CC45 vs. CC5 groupings. 
 
 
Work or energy of binding to fibronectin  
The maximum force value is a useful measure of adhesion but it is only one point on a 
retraction curve.  Therefore, I also calculated the energy of adhesion by integrating force with 
respect distance (see red-shaded region in Fig. 2).   This integration protocol was carried out on 
approximately 5% of the 7,519 force-distance profiles analyzed that exhibited a binding event.  
As with the maximum force of adhesion, only those profiles exhibiting distinct sawtooth 
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curvature were included in this analysis.  The PB group had a median energy/work of binding of 
107 aJ.  This value was found to be statistically different from the RB group (average energy= 14 
aJ) (p < 0.0001).  In addition, the CC45 group, with a median energy of 28 aJ, was found to be 
statistically different from the CC5 group, which had an average energy of 126 aJ, as described 
in Figure 5 (p < 0.0001). 
  
 
Figure 5.  Box plots showing the binding energy (attoJoules; 10-18 J) for S. aureus to a fibronectin-coated 
surface. The upper portion each box represent the 75th percentile and the lower portion represent the 25th 
percentile.  The upper part of each line represents the 91st percentile and the lower portion represents the 
9th percentile.  The median is represented by a horizontal line and numerically below the line. P-values 
represented the comparison of the (i) PB vs. RB and (ii) CC45 vs. CC5 groupings. 
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DISCUSSION 
Recently it has been shown that community-associated MRSA strains (a distinct group 
from hospital-associated MRSA strains) are increasingly more prevalent in hospitals (8).  Thus, 
describing the infectivity elements of such MRSA bacteria is of continuing importance.  Many 
parameters have been used to describe or classify clinically relevant S. aureus isolates, and in 
particular, MRSA isolates.  For instance, genetic descriptions such as CCs or clinical 
descriptions such as PB vs. RB are both used to classify S. aureus isolates.  
Fourteen clinical MRSA isolates, originating from a multinational S. aureus bacteremia 
clinical trial collection, were analyzed using AFM with a fibronectin-baited tip.  The resulting 
force-profiles were analyzed for frequency of binding (percentage), maximal force of binding 
(nN), and energy of binding (aJ). 
The clinical comparison of persistent bacteria (PB) to resident bacteria (RB) is based on 
the S. aureus isolate’s ability to establish bacteremia.  This classification system is based strictly 
on clinical observation of patients infected with MRSA.  The statistical analysis of the AFM data 
show that PB isolates bind more frequently, with stronger binding force, and greater binding 
energy then the RB isolates (Table 3).  These results are consistent with the clinical outcome.  
PB isolates are able to establish positive blood cultures after >7 days of therapy..  
There is also evidence that relates CC to the clinical patient outcome.  Isolates of CC5 
and CC30 have been found associated with increased levels of hematogenous complications (9).  
However, for the AFM data, only CC5 and CC8/1 groups were shown to be statistically different 
under the binding frequency parameter.  All other comparisons under other parameters were 
shown to be significantly different (Table 3).  It appears that CC5 and 8 are capable of stronger 
binding forces and increased binding energies.  However, none of these clonal complexes have 
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been shown to be more virulent except CC1 and CC5 (25).  In addition, although both CC 
groupings and clinical (PR/RB) groupings individually show differences among isolates, no CC 
group clearly fell into clinical PB or RB groups.  The clinical PB group contained 2 CC45, 3 
CC5, and 2 CC8 isolates whereas the clinical RB group contained 3 CC45, 2 CC5, 1 CC8, and 1 
CC1 isolate.  Classifying isolates based on specific genetic markers has advantages such as ease 
of identifying a S. aureus isolates obtained from a patient as particularly invasive.  However, CC 
does not seem to correlate to the specific invasiveness of S. aureus isolates obtained from clinical 
patients.  In addition, it must be remembered that whatever the classification used for S. aureus, 
binding to fibronectin is the first step for a successful infection.     
In addition, the classification of MRSA clinically as a PB or RB isolate seems sufficient.  
Not only is there a clear difference between these two groups of isolates, with PB isolates 
showing a specifically increased binding frequency, energy of binding, and maximal force of 
binding, but there also is an established clinical difference between the two isolate groupings as 
described (25).  
In conclusion, this study helps to establish key differences between PB and RB isolates.  
These differences validate the use of the described PB/ RB clinical classification system used to 
describe and treat infections caused by S. aureus. As some infections with methicillin-resistant S. 
aureus (MRSA) have been shown to be fatal and others to cause necrotizing fasciitis, necrotizing 
pneumonia, purpura fulminans, pyomyositis and sepsis, validation of such a clinical 
classification system is important (11). 
While this study demonstrates a correlation between clinical outcome (PB vs. RB) and 
binding of S. aureus to fibronectin-substrates, it does not provide a possible explanation for the 
observed difference.  There are at least three possible explanations.  One explanation is that the 
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PB isolates could produce more FnBPs then the RB isolates.  Another explanation could be that 
the PB isolates produce additional receptors that bind to fibronectin.  A third explanation could 
be that there are differences in the amino acid sequence of FnBPs from the PB vs. RB isolates.  
A recent study suggests that this last explanation may be the most plausible (15).  However, 
future studies will be necessary to explore these issues.   
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